Griseofulvin and terbinafine in the treatment of tinea capitis in children

New Zealand Medical Journal

Volumn 111, Issue 1060, 1998, Pages 55-57

  Rademaker, M ^a,b   Havill, S ^a  

^a WAIKATO DISTRICT HEALTH BOARD   (New Zealand)

^b Dermatology Department   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ECONAZOLE; GRISEOFULVIN; ITRACONAZOLE; KETOCONAZOLE; TERBINAFINE;

ADOLESCENT; ALOPECIA; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG COST; DRUG EFFICACY; FEMALE; GASTROINTESTINAL DISEASE; HAIR GROWTH; HUMAN; IMMUNOPATHOLOGY; LYMPHOCYTOPENIA; MALE; MICROSPORUM CANIS; NEUROLOGIC DISEASE; PEDIATRICS; SKIN MANIFESTATION; TINEA CAPITIS; TREATMENT CONTRAINDICATION; TREATMENT FAILURE; TREATMENT OUTCOME; TRICHOPHYTON;

ADOLESCENT; ANTIFUNGAL AGENTS; CHILD; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; GRISEOFULVIN; HUMANS; MALE; MICROSPORUM; NAPHTHALENES; PROSPECTIVE STUDIES; TINEA CAPITIS; TREATMENT OUTCOME; TRICHOPHYTON;

EID: 0032570854     PISSN: 00288446     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Friedman IJ, Howard R. Tinea capitis: epidemiology, diagnosis, treatment and control. J Am Acad Dermatol 1994; 31: S42-6.
2. Sharma V, Hall JC, Knapp JF, et al. Scalp colonization by Trichophyton tonsurans in an urban pediatric clinic. Asymptomatic carrier state. Arch Dermatol 1988; 124: 1511-3.
3. Rogers M, Muir D, Pritchard R. Increasing importance of Trichophyton tonsurans in childhood tinea in New South Wales. The pattern of childhood tinea in New South Wales, Australia 1979-1988: the emergence of Trichophyton tonsurans as an important pathogen in tinea capitis in white children. Australas J Dermatol 1993; 34: 5-8.
4. Leeming JG, Elliott TS. The emergence of Trichophyton tonsurans tinea capitis in Birmingham, UK. Br J Dermatol 1995; 133: 929-31.
5. Korstanje MJ, Staats CG. Tinea capitis in Northwestern Europe 1963-1993: etiologic agents and their changing prevalence. Int J Dermatol 1994; 33: 548-9.
6. Babel DE, Baughman SA. Evaluation of the adult carrier state in juvenile tinea capitis caused by Trichophyton tonsurans. J Am Acad Dermatol 1989; 21: 1209-12.
7. Vargo K, Cohen BA. Prevalence of undetected tinea capitis in household members of children with disease. Pediatrics 1993; 92: 155-7.
8. Greer DL. Treatment of symptom free carriers in management of tinea capitis. Lancet 1996; 348: 350.
9. Desgarennes MD, Godoy MR, Palencia AB. Therapeutic efficacy of terbinafine in the treatment of three children with tinea tonsurans. J Am Acad Dermatol 1996; 35: 114-6.
10. Jones TC. Overview of the use of terbinafine (Lamisil) in children. Br J Dermatol 1995; 132: 683-9.
11. Nejjam F, Zagula M, Cabiac MD, et al. Pilot study of terbinafine in children suffering from tinea capitis: evaluation of efficacy, safety and pharmacokinetics, Br J Dermatol 1995; 132: 98-105.
12. Lopez Gomez S, Del Palacio A, Van Cutsem J, et al. Itraconazole versus griseofulvin in the treatment of tinea capitis: a double blind randomized study in children. Int J Dermatol 1994; 33: 743-7.
13. Haroon TS, Hussain I, Mahmood A, et al. An open clinical study of the efficacy and safety of oral terbinafine in dry non inflammatory tinea capitis. Br J Dermatol 1992; 126: Suppl 39: 47-50.
14. Drake LA, Dinehart SM, Farmer ER, et al. Guidelines of care for superficial mycotic infections of the skin: tinea capitis and tinea barbae. Guidelines/Outcomes Committee. American Academy of Dermatology. J Am Acad Dermatol 1996; 34(2 Pt 1): 290-4.
15. Champion RH, Burton JL, Ebling FGJ. Textbook of Dermatology. 5th ed. London: Blackwell Science Publications, 1992. p1150-2.
16. Jensen JC. Clinical pharmacokinetics of terbinafine. Clin Exp Dermatol 1989; 14: 110-3.
17. Dragos V, Lunder M. Lack of efficacy of 6 week treatment with oral terbinafine for tinea capitis due to Microsporum canis in children. Pediatr Dermatol 1997; 14: 46-8.